LinkOPH

LAS VEGAS — Ophthalmology’s next golden age of innovation is comprised of three factors: the market for eye care, the ophthalmology ecosystem and where ophthalmology is from a scientific standpoint, according to Brent Saunders, president and CEO of Allergan.“There have been many golden ages of innovation in ophthalmology. When I started to look at the factors that led to a golden age of innovation, it occurred to me that we are on the cusp of entering a new or next golden age of innovation in eye care,” Saunders said during (Read more...)

LAS VEGAS — At the Ophthalmology Innovation Summit, Robert Greenberg, MD, chairman of Second Sight, discusses the company’s latest innovations for treating blindness, including information on the Argus II retinal prosthesis system.

Read more →

LAS VEGAS — At the Ophthalmology Innovation Summit, Vicken Karageozian, MD, chief technical officer of Allegro Ophthalmics, discusses progress of the company’s Luminate (ALG-1001) program and gives an update on phase 2b clinical trials and use of the integrin peptide across multiple vitreoretinal indications, including vitreomacular traction, diabetic macular edema and posterior vitreous detachment.

Read more →

LAS VEGAS — At the Ophthalmology Innovation Summit, John A. Hovanesian, MD, FACS, founder of MDbackline, discusses the advantages of the software’s automated patient contact system, which facilitates follow-up care and helps educate patients.

Read more →

LAS VEGAS — At the Ophthalmology Innovation Summit, Nick Tarantino, OD, chief global clinical research and regulatory affairs officer for AcuFocus, discusses visual results achieved in presbyopia correction with the Kamra inlay as well as the IC-8 IOL in development.

Read more →